This administration is so short sided. Diversity in clinical trials is important not everyone will react to the medication the same. This impacts the safety of patients. You look at history and you can see the negative impact of biased clinical studies.
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-drops-web-pages-improving-clinical-trial-diversity-2025-01-24/